Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?

Neurologia i Neurochirurgia Polska

Volumn 43, Issue 5, 2009, Pages 428-432

  Ashtari, Fereshteh ^a   Fatehi, Farzad ^a   Shaygannejad, Vahid ^a   Chitsaz, Ahmad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amantadine; Effects; Fatigue severity scale; Multiple sclerosis; Persian

Indexed keywords

AMANTADINE; BETA INTERFERON; CYTOTOXIC AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; INSOMNIA; IRAN; MALE; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AMANTADINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISABILITY EVALUATION; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; IRAN; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449642846     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. de Castro P., Abad A., Bárcena E., et al. Multiple sclerosis and fatigue. An Sist Sanit Navar 2000; 23: 441-450.
2. Johnson S.L. The concept of fatigue in multiple sclerosis. J Neurosci Nurs 2008; 40: 72-77.
3. Kos D., Kerckhofs E., Nagels G., et al. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 2008; 22: 91-100. (Pubitemid 350223141)
4. Lapierre Y., Hum S. Treating fatigue. Int MS J 2007; 14: 64-71.
5. Bethoux F. Fatigue and multiple sclerosis. Ann Readapt Med Phys 2006; 49: 265-271.
6. Zifko U.A. Management of fatigue in patients with multiple sclerosis. Drugs 2004; 64: 1295-1304. (Pubitemid 38916343)
7. Zifko U.A. Therapy of day time fatigue in patients with multiple sclerosis. Wien Med Wochenschr 2003; 153: 65-72. (Pubitemid 36286655)
8. Brola W., Ziomek M., Czernicki J. Fatigue syndrome in chronic neurological disorders. Neurol Neurochir Pol 2007; 41: 340-349. (Pubitemid 47496618)
9. Pucci E., Branas P., D'Amico R., et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2007; (1): CD002818.
10. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003; 9: 219-227. (Pubitemid 36686688)
11. Saadatnia M., Etemadifar M., Fatehi F., et al. Short-term effects of prolonged fasting on multiple sclerosis. Eur Neurol 2009; 61: 230-232.
12. Krupp L.B., LaRocca N.G., Muir-Nash J.F., et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
13. MacAllister W.S., Krupp L.B. Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am 2005; 16: 483-502.
14. Murray T.J. Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci 1985; 12: 251-254.
15. Kronenberger B., Berg T., Herrmann E., et al. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. Eur J Gastroenterol Hepatol 2007; 19: 639-646. (Pubitemid 47067061)
16. Evidente V.G., Adler C.H., Caviness J.N., et al. Amantadine is beneficial in restless legs syndrome. Mov Disord 2000; 15: 324-327. (Pubitemid 30166743)
17. Martinez-Martin P., Catalan M.J., Benito-Leon J., et al. Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006; 15: 597-606. (Pubitemid 43843968)
18. Garssen M.P., Schmitz P.I., Merkies I.S., et al. Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial. J Neurol Neurosurg Psychiatry 2006; 77: 61-65. (Pubitemid 43022692)
19. Tomassini V., Pozzilli C., Onesti E., et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double- blind, crossover trial. J Neurol Sci 2004; 218: 103-108. (Pubitemid 38169402)
20. Figved N., Benedict R., Klevan G., et al. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Mult Scler 2008; 14: 1084-1090.
21. Arnett P.A., Barwick F.H., Beeney J.E. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 2008; 14: 691-724.